Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ismail

Showing results (1351-1360 of 1,394) with videos related to

Pageof 140
Sort By:
Alimentary Pharmacology & Therapeutics|December 2, 2017
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in EgyptH Omar, W El Akel, T Elbaz, et al.
Journal of Hepatology|December 11, 2017
Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experienceAisha Elsharkawy, Maissa El-Raziky, Wafaa El-Akel, et al.
Clinical Medicine Insights. Oncology|October 11, 2016
Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?Nader I Al-Dewik, Hisham M Morsi, Muthanna M Samara, et al.
Plos Neglected Tropical Diseases|June 12, 2013
Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasisJohn K Thuita, Kristina K Wolf, Grace A Murilla, et al.
Scientific Reports|November 23, 2025
Morphology dependent antibacterial activity of zinc oxide nanoparticles against clinically relevant bacteriaNaila Zubair, Rasha Mohammed Sajet Al-Oqaili, Muhammad Junaid Yousaf, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2011
The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNAA Daliry, M Q Pires, C F Silva, et al.
Journal of Biochemical and Molecular Toxicology|January 12, 2025
Harnessing miRNAs: A Novel Approach to Diagnosis and Treatment of TuberculosisAhmed S Doghish, Ahmed I Abulsoud, Yara A Nassar, et al.
Medicina (Kaunas, Lithuania)|October 26, 2024
Relation between Urine Cytological Findings and Renal Function in Patients with Kidney Stones in Taif, Saudi ArabiaSahar Ali Qahtani, Khadiga A Ismail, Howaida M Hagag, et al.
Biomolecules & Biomedicine|April 2, 2025
Unveiling the synergistic power of 3-hydrazinoquinoxaline-2-thiol and vancomycin against MRSA: An <i>in vitro </i>and <i>in silico</i> evaluationOhood S Alharbi, Mohanned Talal Alharbi, Mazen A Ismail, et al.
Journal of Medicinal Chemistry|January 16, 2019
Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell ModelSabine Depauw, Mélanie Lambert, Samy Jambon, et al.
Pageof 140

Showing results (1351-1360 of 1,394) with videos related to

Sort By:
Pageof 140
Alimentary Pharmacology & Therapeutics|December 2, 2017
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in EgyptH Omar, W El Akel, T Elbaz, et al.
Journal of Hepatology|December 11, 2017
Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experienceAisha Elsharkawy, Maissa El-Raziky, Wafaa El-Akel, et al.
Clinical Medicine Insights. Oncology|October 11, 2016
Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?Nader I Al-Dewik, Hisham M Morsi, Muthanna M Samara, et al.
Plos Neglected Tropical Diseases|June 12, 2013
Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasisJohn K Thuita, Kristina K Wolf, Grace A Murilla, et al.
Scientific Reports|November 23, 2025
Morphology dependent antibacterial activity of zinc oxide nanoparticles against clinically relevant bacteriaNaila Zubair, Rasha Mohammed Sajet Al-Oqaili, Muhammad Junaid Yousaf, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2011
The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNAA Daliry, M Q Pires, C F Silva, et al.
Journal of Biochemical and Molecular Toxicology|January 12, 2025
Harnessing miRNAs: A Novel Approach to Diagnosis and Treatment of TuberculosisAhmed S Doghish, Ahmed I Abulsoud, Yara A Nassar, et al.
Medicina (Kaunas, Lithuania)|October 26, 2024
Relation between Urine Cytological Findings and Renal Function in Patients with Kidney Stones in Taif, Saudi ArabiaSahar Ali Qahtani, Khadiga A Ismail, Howaida M Hagag, et al.
Biomolecules & Biomedicine|April 2, 2025
Unveiling the synergistic power of 3-hydrazinoquinoxaline-2-thiol and vancomycin against MRSA: An <i>in vitro </i>and <i>in silico</i> evaluationOhood S Alharbi, Mohanned Talal Alharbi, Mazen A Ismail, et al.
Journal of Medicinal Chemistry|January 16, 2019
Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell ModelSabine Depauw, Mélanie Lambert, Samy Jambon, et al.
Pageof 140